Related Experiment Video
Updated: Jun 21, 2026
06:09
Development of a Preclinical Inhalation Model to Test Vaporized Cannabis Distillates
Published on: May 30, 2025
Effects of cannabis on lung function: a population-based cohort study
1Dunedin Multidisciplinary Health and Development Research Unit, Dunedin School of Medicine, University of Otago, Dunedin, New Zealand. bob.hancox@otago.ac.nz
The European Respiratory Journal
|August 15, 2009
Summary
Cannabis use may increase lung volumes and airway resistance, unlike tobacco, which is linked to reduced lung function. This study highlights distinct effects of cannabis versus tobacco on respiratory health.
Area of Science:
- Pulmonary Medicine
- Respiratory Physiology
- Cannabis Research
Background:
- The impact of cannabis on lung function is not well understood and may differ from tobacco.
- Previous research has yielded conflicting results regarding cannabis and lung health.
Purpose of the Study:
- To compare the associations between cannabis use and tobacco use with lung function measures.
- To investigate potential differences in respiratory effects between cannabis and tobacco.
Main Methods:
- A population-based cohort study of 1,037 participants was conducted.
- Cannabis and tobacco use were self-reported at multiple ages (18, 21, 26, 32 years).
- Lung function was assessed using spirometry, plethysmography, and carbon monoxide transfer factor at age 32, with adjustments for concurrent substance use.
Main Results:
- Cumulative cannabis use was associated with increased lung volumes (forced vital capacity, total lung capacity, functional residual capacity, residual volume) and higher airway resistance.
- Cannabis use did not show associations with airflow obstruction (forced expiratory volume in 1 second, forced expiratory ratio) or impaired gas transfer (transfer factor).
- Tobacco use was linked to decreased forced expiratory volume in 1 second, reduced forced expiratory ratio, lower transfer factor, and increased static lung volumes, but not airway resistance.
Conclusions:
- Cannabis and tobacco exert different effects on lung function.
- Cannabis use appears to be associated with lung hyperinflation and increased large-airways resistance.
- Evidence for airflow obstruction or gas exchange impairment due to cannabis use was minimal.
Related Concept Videos
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
01:20COPD: Pathogenesis and Clinical Features
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
01:24Chronic Obstructive Pulmonary Disease
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
01:25Statistical Methods for Analyzing Epidemiological Data
Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
01:23Chronic Obstructive Pulmonary Disease I: Introduction
Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...